NASH - Nonalcoholic Steatohepatitis research hub
6 indexed studies · 3 currently recruiting
- active not recruitingPHASE3
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
This study is looking into a new medication called lanifibranor for adults with a liver condition called NASH (Nonalcoholic Steatohepatitis) and significant liver scarring (fibrosis F2 or F3). Researchers want to see if it's safe and helps improve the liver condition.
United States · Argentina · Australia - recruitingPHASE3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
This study is testing a new medicine, efruxifermin, for people with a serious liver condition called NASH/MASH cirrhosis. It's to see if the medicine helps improve liver health in those with scarring that hasn't yet caused severe problems.
United States · Argentina · Australia - recruiting
The European NAFLD Registry
This study aims to understand fatty liver disease (NAFLD) better. Researchers collect information and samples from patients across Europe to find new ways to detect and monitor the disease, especially how it progresses from fatty liver to more serious conditions like fibrosis.
Belgium · Finland · France - active not recruitingPHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
This study is testing a new medicine, MGL-3196, for people with a type of liver disease called NASH. Researchers want to see if the medicine can improve liver health and stop the disease from getting worse. It involves regular check-ups and liver biopsies.
United States · Australia · Austria - enrolling by invitationPHASE4
Semaglutide vs Sitagliptin
This study looks at two diabetes medicines, Semaglutide and Sitagliptin, in people who have had a liver transplant. It checks how well they control blood sugar and body weight, and if they are safe.
Canada - active not recruiting
LITMUS Imaging Study
This study looks at new ways to check liver health in people with fatty liver disease (NAFLD) without taking a biopsy. It uses special scans to see how well these new checks work compared to traditional methods and how liver disease changes over time.
United States · Finland · France